Transforming growth factor-beta1 is not involved in TCDD-dependent release from contact inhibition in WB-F344 cells.
Hoelper
Peter
P
Institute of Toxicology, Johannes Gutenberg-University, Obere Zahlbacherstrasse 67, 55131, Mainz, Germany.
Faust
Dagmar
D
Oesch
Franz
F
Dietrich
Cornelia
C
D000818:Animals; D015153:Blotting, Western; D002274:Carcinogens, Environmental / Q000633:toxicity*; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects*; D004247:DNA / Q000096:biosynthesis; D008099:Liver / Q000166:cytology; D000072317:Polychlorinated Dibenzodioxins / Q000633:toxicity*; D017346:Protein Serine-Threonine Kinases; D051381:Rats; D000077294:Receptor, Transforming Growth Factor-beta Type II; D018125:Receptors, Transforming Growth Factor beta / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000378:metabolism*; D053773:Transforming Growth Factor beta1
D002274:Carcinogens, Environmental; D000072317:Polychlorinated Dibenzodioxins; D018125:Receptors, Transforming Growth Factor beta; C508962:Tgfb1 protein, rat; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D004247:DNA; D017346:Protein Serine-Threonine Kinases; D000077294:Receptor, Transforming Growth Factor-beta Type II